What is the approach to treating a patient with suspected methanol toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Treating Suspected Methanol Toxicity

Immediately initiate fomepizole treatment upon suspicion of methanol poisoning based on clinical presentation or laboratory findings, without waiting for confirmatory methanol levels, and prepare for urgent hemodialysis if severe acidosis, visual disturbances, or methanol concentration ≥50 mg/dL are present. 1

Immediate Recognition and Antidote Administration

Clinical Suspicion Triggers

Begin treatment immediately when any of the following are present:

  • Patient history of methanol ingestion 1
  • Anion gap metabolic acidosis (anion gap calculated as Na⁺ - [Cl⁻ + HCO₃⁻]) 2
  • Elevated osmolar gap (>10-50 mOsm/kg depending on context) 2
  • Visual disturbances (ranging from blurred vision to blindness) 1, 3
  • Documented serum methanol concentration >20 mg/dL 1

First-Line Antidote: Fomepizole

Fomepizole is the preferred antidote over ethanol due to superior safety profile, easier dosing, and fewer adverse effects 3. Dosing regimen:

  • Loading dose: 15 mg/kg IV over 30 minutes 1
  • Maintenance: 10 mg/kg IV every 12 hours for 4 doses 1
  • Then 15 mg/kg IV every 12 hours until methanol <20 mg/dL and patient asymptomatic with normal pH 1

Critical administration note: Do not use polycarbonate syringes or needles, as fomepizole interacts with polycarbonate 1. Dilute in at least 100 mL of 0.9% sodium chloride or 5% dextrose 1.

Stratification for Hemodialysis

Category 1: Critically Ill Patients Requiring IMMEDIATE Hemodialysis

Initiate hemodialysis urgently if ANY of the following are present:

  • Methanol concentration ≥50 mg/dL 1, 3
  • Severe metabolic acidosis with base deficit >15 mM or pH <7.20 4
  • Visual disturbances of any degree 4, 3
  • Anion gap >27 mmol/L 2
  • Renal failure 1
  • Coma or seizures 5

Rationale: Hemodialysis removes the toxic metabolite formic acid (the primary cause of visual toxicity and acidosis), corrects severe metabolic abnormalities, and reduces formate toxicity 4, 3. The removal of methanol itself is secondary when fomepizole is administered, as further formic acid production is blocked 4.

Category 2: Stable Patients - Delayed or No Hemodialysis

For patients with:

  • Less severe metabolic acidosis (base deficit <15 mM) 4
  • No visual disturbances 4
  • Methanol concentration <50 mg/dL 1

Treatment approach: Administer fomepizole and sodium bicarbonate; hemodialysis may be delayed or potentially avoided 4. These patients will not develop additional clinical features when adequate fomepizole and bicarbonate are provided 4.

Hemodialysis Technical Specifications

When hemodialysis is indicated:

  • Dialyzer: Large surface area ≥1.5 m² 5
  • Blood flow rate: 250-350 mL/min 5
  • Dialysate flow rate: 500 mL/min 5
  • Duration: 4-6 hours per session 5

Fomepizole Dosing During Hemodialysis

Increase dosing frequency to every 4 hours during hemodialysis as fomepizole is dialyzable 1. Specific timing:

  • If <6 hours since last dose at hemodialysis start: do not give additional dose 1
  • If >6 hours since last dose: administer next scheduled dose 1
  • Dose every 4 hours throughout hemodialysis 1
  • At hemodialysis completion: adjust based on time since last dose (see detailed algorithm in FDA label) 1

Adjunctive Therapies

Sodium Bicarbonate

Correct metabolic acidosis aggressively with IV sodium bicarbonate 1, 3. Acidosis increases formic acid toxicity by enabling greater cellular diffusion 3.

Folinic Acid (Leucovorin)

Administer IV folinic acid to enhance formic acid metabolism to carbon dioxide and water 3. This is particularly important for patients with ophthalmologic abnormalities or significant acidosis 3.

Treatment Cessation Criteria

Discontinue fomepizole when ALL of the following are met:

  • Methanol concentration <20 mg/dL or undetectable 1
  • Patient asymptomatic 1
  • Normal pH 1

Critical Pitfalls to Avoid

  1. Never delay treatment waiting for confirmatory methanol levels - begin fomepizole immediately upon clinical suspicion 1, 3

  2. Do not underestimate the severity based on initial presentation - there is typically a 12-24 hour latent period before severe acidosis and visual impairment develop 3

  3. Avoid using ethanol as first-line antidote when fomepizole is available - ethanol has complex dosing, difficulty maintaining therapeutic levels, requires more monitoring, and causes more adverse effects 3

  4. Do not withhold hemodialysis in critically ill patients even if fomepizole is administered - dialysis is essential for removing formic acid and correcting severe acidosis 4, 5

  5. Monitor for alcohol withdrawal in patients with concomitant alcohol use disorder, especially during hemodialysis 6

Consultation

Contact a poison control center or medical toxicologist immediately for expert guidance, as methanol poisoning requires specialized treatment 6.

References

Guideline

Diagnosis of Methanol Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemodialysis for methyl alcohol poisoning: a single-center experience.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.